NeurOdys Therapeutics

Private

AmsterdamHealthcare & Life Scienceshttp://neurodys.com/

Last Round

Pre Seed

Mar 15, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NeurOdys Therapeutics is a biotechnology company developing small molecule therapies for neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Application

Keywords

small molecule therapeuticsneurodegenerative disordersAI drug discoverydisease modifying therapiesAI biotechAlzheimer's diseaseParkinson's diseasecomputational drug discoveryneurotherapeuticsin silico drug discoverypreclinical stagedrug developmentdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeurOdys Therapeutics Comparables

Compare NeurOdys Therapeutics with similar companies based on industry and business-model similarity.

NeurOdys Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Mair Therapeutics	90%
Polku Therapeutics	78%
SciNeuro	76%

View all Comparables

NeurOdys Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Mar 15, 2026

View all Funding Rounds

NeurOdys Therapeutics Investors

Notable investors and investment history

NeurOdys Therapeutics investors
Investor	Rounds
Expert Systems Inc.	Pre Seed
Torrey Pines Investment LLC	Pre Seed
Rambam AG	Pre Seed
NLC Health Ventures	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 15, 2026
Led by NLC Health Ventures and Rambam AG.

View all signals

NeurOdys Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NeurOdys Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeurOdys Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAmsterdam

Year Founded2024

Last FundingMar 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.